{"name":"Helse Stavanger HF","slug":"helse-stavanger-hf","ticker":"","exchange":"","domain":"","description":"Helse Stavanger HF is a healthcare organization based in Norway, primarily involved in the provision of healthcare services and potentially engaged in pharmaceutical activities. The company has a portfolio of 9 drugs, with some in early development stages and others already marketed.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"Etalpha","genericName":"Etalpha","slug":"etalpha","indication":"Other","status":"phase_2"},{"name":"Acetylsalicylate","genericName":"Acetylsalicylate","slug":"acetylsalicylate","indication":"Other","status":"phase_1"},{"name":"Insulin dosing based on SMBG chart and education","genericName":"Insulin dosing based on SMBG chart and education","slug":"insulin-dosing-based-on-smbg-chart-and-education","indication":"Other","status":"marketed"},{"name":"Phenserine","genericName":"Phenserine","slug":"phenserine","indication":"Other","status":"phase_1"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"EPA / DHA / Alpha-Tocopherol","genericName":"EPA / DHA / Alpha-Tocopherol","slug":"epa-dha-alpha-tocopherol","indication":"Cardiovascular disease prevention or management (Phase 3 indication under investigation)","status":"phase_3"}]}],"pipeline":[{"name":"EPA / DHA / Alpha-Tocopherol","genericName":"EPA / DHA / Alpha-Tocopherol","slug":"epa-dha-alpha-tocopherol","phase":"phase_3","mechanism":"A combination of omega-3 fatty acids (EPA and DHA) and vitamin E that reduces inflammation and oxidative stress to support cardiovascular and metabolic health.","indications":["Cardiovascular disease prevention or management (Phase 3 indication under investigation)"],"catalyst":""},{"name":"Etalpha","genericName":"Etalpha","slug":"etalpha","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Acetylsalicylate","genericName":"Acetylsalicylate","slug":"acetylsalicylate","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Insulin dosing based on SMBG chart and education","genericName":"Insulin dosing based on SMBG chart and education","slug":"insulin-dosing-based-on-smbg-chart-and-education","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Phenserine","genericName":"Phenserine","slug":"phenserine","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":5,"phaseCounts":{"phase_3":1,"phase_2":1,"phase_1":2,"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}